Plain-English translation of NCT06572410 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the EnVisio Navigation System, a surgical guidance tool that helps doctors precisely locate and remove breast cancers during breast-conserving surgery. The system uses special markers called SmartClips to help surgeons see exactly where the tumor is and ensure they remove it completely while leaving healthy tissue behind. Researchers want to see how well this technology works and whether it improves surgical outcomes.
Standard breast cancer surgery can sometimes miss cancer at the edges of the removed tissue, requiring a second surgery. This trial aims to see if the new guidance system helps surgeons get clean margins on the first try, reducing the need for repeat procedures and improving outcomes for people choosing to keep their breast.
If you join this trial, you would have SmartClip markers placed in or near your tumor before surgery to help guide your surgeon during the operation. During your breast-conserving surgery, your surgeon would use the EnVisio Navigation System to help locate the tumor and remove it with clear margins. Researchers would collect information about your surgery, including timing, images, and pathology results to see how well the system worked.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States
Sponsor
Elucent Medical
Enrollment target
~200 participants
Started
August 2024
Primary completion
February 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jason A Boardman, MD
Elucent Medical